Stock image T Cell Therapy
T-lymphocytes And Dendritic Cells, 3D-rendering; Dendritic Cells Are Antigen-presenting Cells Of The Immune System. They Process Antigen Material And Present It On The Cell Surface To The T-cells. Illustration
Image, 2.23MB, 4000 × 3000 jpg
3d Computer Illustration Of A Chimeric Antigen Receptor. CARs Are Engineered Cell Receptors That Allow T Cells To Recognize And Attack Cancer Cells In A Specific Way. They Are Built By Connecting Several Functional Parts From Different Proteins.
Image, 8.45MB, 8000 × 6000 jpg
3d Computer Illustration Of A Dendritic Cell. They Areantigen-presenting Cells Of The Immune System. Their Main Function Is To Process Antigen Material And Present It On The Cell Surface To The T Cells Of The Immune System. They Are Messengers Betwe
Image, 5.2MB, 8000 × 6000 jpg
3d Computer Illustration Of A Chimeric Antigen Receptor. CARs Are Engineered Cell Receptors That Allow T Cells To Recognize/attack Specifically Cancer Cells. A Signal Protein Is Attached To The Intracellular Domain.
Image, 3.45MB, 8000 × 6000 jpg
3d Computer Illustration Of A Chimeric Antigen Receptor. CARs Are Engineered Cell Receptors That Allow T Cells To Recognize/attack Specifically Cancer Cells. A Signal Protein Is Attached To The Intracellular Domain.
Image, 2.19MB, 8000 × 6000 jpg
Engineered Receptors (light Blue) On The Surface Of A T-lymphocyte Bind Specifically To CD19-antigen Molecules (magenta) On A Leukemia Cell. This Activates A Signal Cascade In The T-cell Leading To The Segregation Of Vesicles That Contain Perforin An
Image, 11.44MB, 8000 × 6000 jpg
CAR T Cell Therapy In Multiple Myeloma (MM) - Isometric View 3d Illustration
Image, 7.7MB, 10000 × 6600 jpg
2D Editable Blue CAR T-Cell Therapy Icon, Monochromatic Isolated Vector, Thin Line Illustration Representing Cell Therapy.
Vector, 0.46MB, 5000 × 5000 eps
The Chimeric Antigen Receptor T (CAR-T) Cell Therapy Is A New Treatment For A Variety Of Cancers. 3d Rendering
Image, 2.01MB, 3776 × 2952 jpg
CAR-T-cell Cancer Therapy. Process Of A T Cell Reprogramming. Immunotherapy Of A Chimeric Antigen Receptor CAR. Cancer Treatment. Genetic Engineering. Vector Illustration
Vector, 0.83MB, 5000 × 3217 eps
T Cell Attacking A Cancer Tumor As An Immunotherapy Immune System Therapy Concept As A Biomedical Or Biomedicine Oncology Treatment As A 3D Render On A White Background.
Image, 5.84MB, 4400 × 4446 jpg
Immunotherapy As A Human Immune System Therapy Concept As A Biomedical Or Biomedicine Oncology Treatment Using The Natural Cancer Fighting Properties Of The Body As A 3D Render.
Image, 7.17MB, 4900 × 3643 jpg
Interactions Of MHC-II With The T-cell Receptor And CD4 And B7-1 With CD-28 Activates T-cells While The Interactions Of P7-1 With CTLA-4 And PD-L1 With PD-1 Deactivates T-cells.
Image, 10.7MB, 8000 × 6000 jpg
T-cells Attacking A Cancer Cell. Isolated On Black Background. 3d Render
Image, 4.29MB, 4000 × 3000 jpg
CAR - Chimeric Antigen Receptor T Cell. Lymphocyte That Have Been Genetically Engineered To Produce An Artificial T-cell Receptor For Use In Immunotherapy. Treatment Of Cancer. Vector Illustration
Vector, 6.18MB, 5000 × 3443 eps
Page 1 >> Next